HBIO
Harvard Bioscience·NASDAQ
--
--(--)
--
--(--)
4.17 / 10
Netural
Money flow analysis registers a healthy 7.19/10, with positive inflow ratios across block, small, medium, large, and extra-large categories, though the overall trend is labeled negative. This suggests short-term buying interest but persistent selling pressure. Analyst coverage is minimal—only one report with a Strong Buy rating—limiting bullish conviction. The neutral analyst sentiment and conflicting flow signals create uncertainty, underscoring the need for vigilance.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
100%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-09-10
InstitutionBenchmark
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for HBIO?
- HBIO holds a Bearish analyst rating, with 100% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 4.17/10 (Netural).
